THURSDAY, Oct. 19, 2023 (HealthDay News) — Millions of people undergo joint replacement surgery every year. To prevent infection, doctors often give them a second antibiotic — but new research suggests this can backfire. Adding a second antibiotic at the time of hip and knee replacement surgery may actually increaseContinue Reading

MONDAY, Oct. 16, 2023 (HealthDay News) — High-risk surgeries are more deadly for Black and Hispanic Americans than for their white counterparts, new research reveals. The study, of more than 1 million procedures performed in U.S. hospitals between 2000 and 2020, found that Black patients were 42% more likely thanContinue Reading

THURSDAY, Oct. 12, 2023 (HealthDay News) — After a massive five-year effort, researchers have unveiled an “atlas” that gives an unprecedented look at the intricacies of the human brain. The atlas, which will be available to researchers everywhere, can be seen as similar to the atlases we all know: aContinue Reading

THURSDAY, Oct. 12, 2023 (HealthDay News) — Treating shoulder pain with steroid shots or removal of cartilage buildup yields the same result as no treatment at all, a Norwegian research team reports. They said their findings call into question treatment guidelines for calcific tendinopathy, a painful condition in the shoulder’sContinue Reading

WEDNESDAY, Oct. 11, 2023 (HealthDay News) — Renting a home, rather than owning it outright, may speed up the body’s aging process, a new study suggests. Researchers found that when compared with people who owned their home outright (no mortgage), those who rented showed signs of faster “biological aging” —Continue Reading

TUESDAY, Oct. 10, 2023 (HealthDay News) — A majority of people who have a minimally invasive heart valve replacement procedure are not getting the recommended cardiac rehab after their surgeries, researchers say. A new study finds that just under 31% of patients who have transcatheter aortic valve replacement (TAVR) areContinue Reading

THURSDAY, Oct. 5, 2023 (HealthDay News) — A nasal spray containing a ketamine derivative appears to beat one of the standard drugs used for people with difficult-to-treat depression, a new clinical trial has found. The trial, of nearly 700 people with treatment-resistant depression, found that esketamine nasal spray was moreContinue Reading